What the Election Results Mean for the Life Sciences Industry: Congress, the Administration, and What Comes Next

The midterm election results, which shift control of Congress, will reshape an already dynamic legal and policy landscape for the life sciences industry.

Arnold & Porter will examine what the results could mean in practice for medical product innovators and investors. Drawing on firsthand experience inside and outside government, the panel will offer practical insights into the evolving priorities in Washington and how companies can navigate the changing political environment.

We hope you’ll join us! We also encourage you to submit questions in advance so our panelists can address the issues most important to you.